Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EVOTAZ safely and effectively. See full prescribing information for EVOTAZ. EVOTAZ® (atazanavir and cobicistat) tablet, for oral useInitial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
EVOTAZ® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in the following populations [see Dosage and Administration (2.2 , 2.3)]: •Adult patients •Pediatric patients weighing at least 35 kg. Use of EVOTAZ in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions [see Clinical Pharmacology (12.4) ].
- generic_name
- atazanavir and cobicistat
- product_names
- atazanavir and cobicistat
- ndc
- 0003-3641, 0003-3641-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en